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Tocarry out their activities, biologicalmacromoleculesbalancedifferent physical traits, suchas stability, interaction
affinity, and selectivity. How such often opposing traits are encoded in a macromolecular system is critical to our
understanding of evolutionary processes and ability to design newmoleculeswith desired functions.Wepresent a
framework for constraining design simulations to balance different physical characteristics. Each trait is
represented by the equilibrium fractional occupancy of the desired state relative to its alternatives, ranging from
none to full occupancy, and the different traits are combined using Boolean operators to effect a “fuzzy”-logic
language for encoding any combination of traits. In another paper, we presented a new combinatorial backbone
design algorithm AbDesign where the fuzzy-logic framework was used to optimize protein backbones and
sequences for both stability and binding affinity in antibody-design simulation.We now extend this framework and
find that fuzzy-logic design simulations reproduce sequence and structure design principles seen in nature to
underlie exquisite specificity on the one hand and multispecificity on the other hand. The fuzzy-logic language is
broadly applicable and could help define the space of tolerated and beneficial mutations in natural biomolecular
systems and design artificial molecules that encode complex characteristics.
© 2014 MRC Laboratory of Molecular Biology. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
The physical properties of biological macromole-
cules are subject to evolutionary selection to improve
organism fitness. In all cases, more than one biomo-
lecular property is under selection, and complex
tradeoffs between competing traits often constrain the
evolutionary optimization process. As a very general
example, all enzymes need to fold into stable
three-dimensional structures in order to function.
Therefore, all enzyme sequences, regardless of
their functional class, encode favorable free-energy
changes for folding [1–4], as well as for their catalytic
function, which itself presents a complex tradeoff
among substrate, transition state, and product binding
affinities [5]. Stability, selectivity, and higher catalytic
efficiency are often opposing objectives in the selec-
tion of biomolecules, such as proteins or RNAs. Thus,
mutations that improve stability often come at the price
of reduced binding affinity [6] and catalytic efficiency
[7–12] and vice versa [13]. Biomolecular specificity,Laboratory of Molecular Biology. Published
tivecommons.org/licenses/by-nc-sa/3.0/).where an enzyme or receptor recognizes a set of
substrates or ligands while excluding noncognate
molecules of similar structure, is often encoded by
features, including sequence and backbone chang-
es, that destabilize undesirable contacts even at the
expense of lower affinity or catalytic efficiency for
the desired partners [14,15]. Conversely, multispecific
enzymes and receptors exhibit similar affinities for a
range of ligands rather than the highest possible
affinity for one [16]. These and many other examples
demonstrate the universal importance of encoding
multiple constraints and tradeoffs for understanding
and engineering biomolecular systems [15].
By controlling all inputs into the process, computa-
tional protein design could provide a way to rigorously
formulate and test our understanding of the physical
constraints that shape biological molecules and partic-
ularly of tradeoffs between these constraints [17]. To
date, however, most design strategies explicitly max-
imizedonedesired physical property througha strategy
broadly known as positive design [18], where theby Elsevier Ltd. This is an open access article under the CC BY-
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4126 ‘Fuzzy’-logic designsequence and structure are optimized to lower the
energy of the target state. Positive design strategies
have led, among other applications, to the design and
experimental validation of thermostabilized protein
variants [19,20], a highly thermostable novel protein
fold [21], idealized natural folds [22], enzymes [23,24],
and protein binders [25–28]. However, the strategy of
maximizing molecular traits stands to reason when
only one molecular trait, such as stability, is optimized
[19–22] orwhenmolecular traits do not tradeoff, that is,
come at the expense of one another. When tradeoffs
apply, maximizing any subset of properties can have
the undesired consequence of disfavoring sequences
that could simultaneously optimize all desired traits, at
least to sufficiency [29].(a)
(c)
(d)Computational design methods that explicitly en-
code multiple constraints have been suggested to
design and analyze specificity and multispecificity.
These methods consider several different states for
the designed molecule in a strategy broadly known as
multistate design. A particularly influential concept has
been to maximize the energy gap between the target
(positive) state and undesired (negative) states to
generate pairs of molecules that interact more
favorably with one another than with homologous
natural partners [30–32]. Conversely, multispecificity
has been analyzed by computationally optimizing the
sum of energies computed for complexes formed
between a hub protein and its ligands, rather than
maximizing the binding energy between any particular(b)
(e)
4127‘Fuzzy’-logic designpair [33]. Recent progress in de novo binder design
relied on optimizing the designed binders' rigidity at
the price of losing favorable contacts with the target
molecule, thus encoding some elements of the
biomolecular tradeoff [34–38]. While these strategies
share in common the concept of encoding multiple
physical traits and tradeoffs between them, they use
fundamentally different analytical frameworks and
heuristics, each tailored to the particular design
objective under consideration.
Here, we develop a general framework for
optimizing biomolecular systems operating under
conditions where tradeoffs emerge. Our framework
is based on equilibrium-thermodynamics principlesFig. 1. Overview of the design algorithm. (a) Fractional occup
free-energy change [Eq. (4)]. ΔGoffset is the free-energy offset at w
occupied. The plot illustrates three regimes: left, high occupancy (
remains largely unaffected by mutations that induce moderate ch
sensitivity, where there is significant change in the fractional occup
and low sensitivity, where the fractional occupancy is negligible a
Venn diagram graphically demonstrates the Boolean operators AN
Y, whereas the NOT gate acts on one state, X. All states are dra
Booleanoperators (NOT,AND, andOR) areused to integrate the v
three fundamental logical operators, we can formulate arguments
properties tradeoff with one another. (d) The design flow chart ex
steps: first, the relevant properties of the system (stability of ind
defined. Second, for each property, the steepness and offset are
objective function is calculated by integrating the sigmoidal functio
used by simulated annealing Monte Carlo sequence optimization
(such as binding, stability, etc.) exemplified here as a function of se
function in n-dimensional space, where n is the number of mutable
outcome of the nonadditive fitness effects of mutations, the limi
different molecular properties.and is supported by recent observations on the
natural and laboratory evolution of biomolecules. In
another paper, we used this new framework to
encode both stability and binding in the design of
antibody binders (Lapidoth et al., unpublished
results). Here, we develop the theoretical grounds
for this framework, generalize it to more complex
relationships between physical traits (including
tradeoffs between constraints), and subject it to
two classic tests of multiconstrained design: the
design of protein-binding specificity and multispeci-
ficity. We find that designed complexes qualitatively
recapitulate the energy and structure features
observed in their natural counterparts.Results
Quantifying physical traits using fractional occupancies
We consider cases where evolutionary selection operates onmolecular properties that are under chemical
equilibrium such as folding, binding, or conformational changes. Most generally, we can describe these
properties as an equilibrium between two states, A and B, where one state, say B, exhibits the desirable
molecular function and thereby promotes “fitness”. For example, A and B could represent, respectively, the
unfolded and folded states of a protein or an RNA molecule, the unbound and bound states of a receptor-ligand
complex, the inactive conformation relative to the active conformations of an enzyme, and so on.
The equilibrium, A ⇌ B, is characterized by an equilibrium constant
K eq ¼ e−ΔG=RT ð1Þ
where ΔG is the free-energy difference between the two states, R is the gas constant, and T is the absolute
temperature. Evolutionacts on this equilibriumby favoring sequences that increase the fractional occupancyofB,
the desirable state. The fractional occupancy, f, is defined as
f ¼ B½ 
A½  þ B½  ð2Þancy shows a sigmoidal dependence on ΔG, the equilibrium
hich the target state, for example, the bound receptor, is half
95–100%) and low sensitivity, where the fractional occupancy
anges in ΔG; middle, medium occupancy (5–95%) and high
ancy due to changes in ΔG; and right, low occupancy (0–5%)
nd remains thus despite moderate improvements in ΔG. (b)
D, OR, andNOT. AND andORgates act on two states X and
wn as circles and the selected area is marked in stripes. (c)
ariables into anoptimization objective function.Bydefining the
encoding combinations of physical properties, includingwhere
emplified for designing for stability and ligand binding, in four
ividual components and affinities between components) are
defined and the sigmoidal function is set [Eq. (6)]. Third, the
ns using Boolean operators. Fourth, the objective function is
. (e) Fitness is a complex function of biomolecular properties
quence exchanges at two positions only; in reality, fitness is a
protein or RNA residues. The landscape's ruggedness is the
ted choice of natural amino acids, and of tradeoffs between
4128 ‘Fuzzy’-logic designwhere [A] and [B] are the concentrations of the two states at chemical equilibrium [39]. Combining
Eqs. (1) and (2) and the thermodynamics definition
K eq ¼ B½ A½  ð3Þ
provides that the fractional occupancy of the desirable molecular state as a function of free-energy change of the
process exhibits a sigmoidal relationship:
f ¼ 1
1þ eΔG=RT ð4Þ
More generally, we rephrase Eq. (4) by adding an offset free-energy term ΔGoffset, at which the target state is half
occupied (i.e., where [A] = [B]; Fig. 1a):
f ¼ 1
1þ e ΔG−ΔGoffsetð Þ=RT ð5Þ
ΔGoffset reflects the energy requirements of a particular characteristic, namely, how favorable should the
optimized trait's energy ΔG be to achieve a target occupancy (e.g., to obtain f N 0.5, ΔGmust be smaller than
ΔGoffset). For example, the receptor-ligand binding energy required to achieve half-maximal receptor occupancy
depends on the ligand concentration; the lower the ligand concentration is, the higher ΔGoffset is, as well as
the more favorable the required binding affinity must be to achieve a certain degree of occupancy [39,40].
Equation (5) asymptotically approaches 1 at negative ΔG values and 0 at positive ΔG values with an
inflection point at ΔG = ΔGoffset (Fig. 1a).
We further rephrase the sigmoidal relationship of Eq. (5) as:
f x ¼ 11þ e x−oð Þs ð6Þ
where x and o are ΔG and ΔGoffset of Eq. (5), respectively, and s determines the slope of the sigmoidal
response to free-energy changes around the inflection point.
Equation (6) generalizes the chemical equilibrium description of the fractional occupancy into the concept of
biomolecular “fitness”, reflecting themolecule's activity or functionality within an organism. The actual functionality
of a biomolecule could have a sharper or a more attenuated dependence on the equilibrium free-energy
change than Eq. (5) dictates. As an example, a molecule that has irreversible effects on cell fate, such as a
nuclease, a protease, or a gene master regulator, may have large biological effects even at low fractional
occupancies; the biomolecular output in this scenario is reproduced by low o and high s values. Conversely, two
competing effector molecules, which bind overlapping sites on their target molecule, may only exert their
biological effects at high occupancy [41] and would be modeled with high o and low s values (guidelines for
determining o and s values are provided in the supplement). For simplicity, in what follows, we refer to fractional
occupancy and biological “fitness” interchangeably, noting that both concepts could be modeled within the
suggested framework.
The fractional occupancy of the desired state is certainly but one of many factors affecting the molecule's
contribution to organism fitness, and expression levels, half-lives, post-translational modifications, and
compartmentalization, play important complementary roles [42–45]. The sigmoidal relationship of Eqs. (5) and
(6) is nevertheless a fundamental property of biomolecular systems, which can quantitatively describe numerous
observations in natural and laboratory evolution, including the response to mutations [46]. Consider a concrete
example of protein stability in mesophilic organisms. Many proteins have ΔGfolding values of −5 kcal/mol [47]
meaning that, under standard conditions, more than 99.97% of the protein is in its folded state [Eq. (4)]. If protein
misfolding [10], quality control [48], expression levels, post-translational modifications, and other extrinsic factors
[49] are held constant, a mutation that decreases ΔGfolding by 2 kcal/mol would increase the folded fraction by less
than 0.03% and would not be subject to strong evolutionary selection; thus, the high fractional occupancy regime
exhibits relatively low sensitivity to mutation (Fig. 1a). By contrast, a protein with ΔGfolding of −1 kcal/mol is 84%
folded, andamutation that decreasesΔGfolding by2 kcal/molwould increase the folded fraction byanappreciable
13%andwould be strongly favoredby selection, leading to high sensitivity tomutation around the sigmoid inflection
point (Fig. 1a). Protein engineering is routinely used to successfully thermostabilize natural proteins [19,20,50,51],
demonstrating that protein stability plateaus in evolution and that natural molecules can be readily engineered for
higher stability. For other examples where physical traits plateau in evolution, see Supplemental Data.
4129‘Fuzzy’-logic designA fuzzy-logic model for the selection of biomolecules with multiple physical traits
From the considerations mentioned above, we infer that a general model for representing multiple
constraints selecting a biomolecule should exhibit two properties: first, a biomolecule's contribution to
organism fitness is not only a function of the free-energy change associated with a physical trait but also a function
of the fractional occupancy of the desirable state (Fig. 1a); and second, the constraints operating on the
evolution of intrinsic physical traits are a complex, nonadditive function of the relevant target-state
occupancies. To model the combination of constraints that shape a biomolecule through evolution, we borrow
a concept from “fuzzy” or many-valued logic systems [52,53]. Fuzzy-logic formulations have been applied to
produce graded rather than all-or-none responses to changes in input. It extends conventional Boolean logic by
proposing that truth (1) and falsehood (0) are only extremes in a continuum of evaluations (0–1) with states that
have intermediate values of truth and falsehood. The combination of molecular constraints, based on the
fractional occupancies described above, lends itself naturally to fuzzy-logic treatment, in which the fractional
occupancy f [Eq. (6)] of any energy term is treated as a Boolean variable and the standard Boolean operators
(NOT, AND, and OR) are used to combine the variables into an optimization objective function (Fig. 1b): for any
two target states (e.g., folded molecule, bound receptor, etc.), the individual fractional occupancies, fx and fy,
are computed using Eq. (6). We thus define, as in Boolean algebra, ¬fx = 1 − fx (NOT fx), fx∧fy = fx*fy (fx AND fy),
and fx∨fy = fx + fy − fx*fy (fxOR fy) (Fig. 1b). In fuzzy logic, values approaching 1 satisfy the constraints embodied
in the argument and values approaching 0 fail to satisfy them (Fig. 1c). By defining the three fundamental logical
operators (Boolean NOT, AND, and OR), any argument comprising any number of constraints relating to energy
evaluations of biomolecular states can be formulated in a statement that resembles natural language. The
fuzzy-logic arguments then serve as objective functions (Fig. 1d) in stochastic sequence optimization in search for
sequences that best conform to the encoded constraints (Fig. 1e). As in a natural language, the objective
functions are an approximate model or representation of reality, and a completely accurate description of the
fitness landscape, accounting for all of the constraints bearing on the biomolecular system, is impossible.
Despite this caveat, the fuzzy-logic system provides a framework for testing our understanding of the main
constraints observed in biomolecular systems by integrating the fractional occupancies of Eq. (6) for each of the
optimized energy criteria (e.g., binding and stability) using Boolean operators (Fig. 1c). In the supplement, we
demonstrate that, under certain conditions, multistate design [30], which optimizes the energy gap between a
target state and its competitors, describes a special case of the sigmoid relationship, assuming one target
and several off-target states. Optimizing the energy gap suffers from a weakness, though, sincemutations are
favored even if they lead to the unwanted destabilization of the designedmolecule or of the desired complex. In the
context of the discussion mentioned above, energy-gap optimization, when applied with no additional constraints,
fails to take into account that biomolecules need to stably fold in order to function correctly. Indeed, previous
studies augmented energy-gap optimization with cutoffs that prevent energy terms from deteriorating beyond a
certain limit [54,55]. Setting strict cutoffs on energy values is, however,more likely to funnel sampling to regions of
sequence space where physical properties are on the border between optimality and suboptimality, potentially
resulting in nonfunctional molecules. Using sigmoidal constraints and tradeoffs rather than strict cutoffs directs the
search toward compromises that raise the chances of satisfying each of the individual constraints at least to
sufficiency.
The fuzzy-logic design framework also allows framing constraints other than of the energy gap between
states. For instance, several successful binder design studies selected sequences based on whether they
encode both active-site side-chain rigidity and high-affinity binding [34–38]. Applying the fuzzy-logic strategy, we
can explicitly optimize these properties during design simulations using the objective function:
O ¼ B a;bð Þ∧S að Þ ð7Þ
(Fig. 1c), where a and b are the designed protein and the target molecule, respectively, and B and S are the
sigmoidal functions [Eq. (6)] for binding energy and stability, respectively. Indeed, in another paper, we
demonstrated that, by optimizing Eq. (7), during antibody-design simulations, one can select antibody
backbone conformations and sequences that exhibit features seen in natural antibody binders, such as conserved
backbone conformations, hydrogen-bonding patterns, and van der Waals packing arrangements observed both
within and between antibodies and their target molecules (Lapidoth et al., unpublished results). Encouragingly, by
optimizingEq. (7), side-chain conformation stability at the designed binding surfacewas comparable and exceeded
that observed in natural antibodies, even though, unlike previous design of function studies [37], side-chain rigidity
was not explicitly used to select models. These results suggest that fuzzy-logic optimization could address some of
the challenges of de novo design of function.
(a) (b)
Fig. 2. Single-state, positive-only design violates the requirement for stability in alternative conformations. The single-state
designed sequence of H-RASPI3K (H-RAS designed to target PI3K) was threaded on H-RASSOS1 backbone (H-RAS in the
SOS-1 bound backbone, cyan), producing the H-RASSOS1*,SOS1 structure (SOS1 is in orange) (a) after side-chain and
rigid-body minimization. This designed sequence compromises the stability of H-RASSOS1 monomer (b) by +173 R.e.u. mainly
due to steric overlap among Y32, E39, and I21.
4130 ‘Fuzzy’-logic designHere, we focus on additional uses for the fuzzy-logic framework and specifically on cases where tradeoffs
between different molecular properties are prominent, such as binding specificity. We note, however, that this
framework can be applied to situations where optimizing one property does not come at the expense of other
properties and to situations where maximizing one trait is deleterious (as such in Ref. [29]). In the latter case,
two sigmoid functions [Eq. (6)] can be applied to constrain the same physical trait, for example, S1(a) and
S2(a), where S1 defines the lower energy bound (with a low o parameter) and S2 defines the upper bound (high
o parameter) of the same energy criterion. The optimization objective function is then defined as:
O ¼ S2 að Þ∧ IS1 að Þ ð8Þ
biasing sequence search toward values intermediate between the two extremes.
Empirical tests of the fuzzy-logic design language
We subject the fuzzy-logic framework to two classic tests of computational protein design: the design of
multispecificity and of orthogonal specificity. These tasks previously required different heuristics and optimization
frameworks [30–33,54–60], but here we show that the fuzzy-logic language provides a unified framework for
analyzing both phenomena.Multispecificity design
As a model for multispecificity design, we select the protein human H-RAS, which has been co-crystallized
with five natural partners [61–64] and was previously subjected to multispecificity analysis [33]. RAS is a
member of the family of small GTP-binding proteins and is involved in regulating signal-transduction
processes leading to cell growth and differentiation by directly controlling multiple pathways [65,66]. H-RAS
presents special challenges to single-state design because it interacts via overlapping surfaces with several
proteins, some of which have different folds and molecular functions, and because the backbone conformation
of H-RAS varies when bound to its different partners [61–64]; the designedH-RAS sequencesmust therefore be
compatible with all of H-RAS's backbone conformations and encode favorable contacts with all of its partners. To
demonstrate the shortcomings of single-state design, that is, design toward any one of the H-RAS-bound
structures, we select for stochastic sequence optimization eight amino acid positions on the H-RAS binding
surface, four in switch region I (Ile36, Glu37, Asp38, and Ser39), two in switch region II (Gln61 and Glu63), and
two outside of these regions (Ile21 and Gln25). With the use of RosettaDesign (Experimental Procedures),
single-state, positive-only design of H-RAS toward each of its partners separately leads to sequences that
4131‘Fuzzy’-logic designincrease H-RAS stability and its binding affinity for that particular target. However, single-state design clearly
violates the requirements of stability in the alternative H-RAS conformations and binding affinity for the other
partners (TableS1). In somecases, the energy violations are severe [more than 10 R.e.u. (Rosettaenergyunits);
Table S1 and Fig. 2], suggesting that optimizing H-RAS to bind any one of its partners alone increases specificity
(as has been observed in other systems [67]) and protein rigidity, at the cost of binding to its other natural
partners.
To model the multiple physical requirements on H-RAS, we use the new framework to encode energy
constraints on all of the observed H-RAS backbone conformations and on binding affinities for all of its partners:
O ¼ B H‐RASSOS1∗;SOS1ð Þ∧B H‐RASPI3K∗;PI3Kð Þ∧B H‐RASBRY‐2RBD∗;BRY‐2RBDð Þ∧B H‐RASRal‐GDS∗;Ral‐GDSð Þ∧B H‐RASRAS‐GAP∗;RAS‐GAPð Þ
∧S H‐RASSOS1∗ð Þ∧S H‐RASPI3K∗
 
∧S H‐RASBRY‐2RBD∗ð Þ∧S H‐RASRal‐GDS∗ð Þ∧S H‐RASRAS‐GAP∗ð Þ ð9Þ
where O is the optimization objective function, H-RAS* is the designed H-RAS protein, and B and S are sigmoidal
functions for binding and stability, respectively (see Experimental Procedures). Subscripts in Eq. (9) denote which
backbone conformation is used for modeling H-RAS; thus, H-RASSOS1* denotes the designed H-RAS sequence
modeled on the SOS1-bound backbone conformation.
Each of the functions (B and S) of Eq. (9) requires parameterization of the offset (o) and slope (s) as defined
in Eq. (6). The offset and slope parameters were determined according to the guidelines in the supplement.
We conduct 4000 independent design simulations starting from two single-state designed complexes as
representatives of two different H-RAS-bound complexes, H-RAS,SOS1 and H-RAS,Ral-GDS, whereby the
eight selected H-RAS positions are optimized to bind to each partner separately. In each simulation, the
H-RAS sequence is subjected to nondeterministic simulated annealing Monte Carlo optimization with Eq. (9)
serving as the optimization objective function (Fig. 1d and Experimental Procedures), and the resulting design
variants are ranked according to the objective function [Eq. (9)]. In both cases, the top-ranked designs have
binding affinities and stabilities similar to those computed for the natural H-RAS structures. Further, the
top-ranked designs show favorable H-RAS-ligand molecular contacts as observed in the natural H-RAS
(Fig. 3).
As expected, Monte Carlo sequence optimization does not converge on a single solution but rather
produces a large landscape of sequences that are compatible with the constraints defined by the objective
function. As the objective function of Eq. (9) encodes 10 different fractional occupancies (five each for binding
and H-RAS stability), we set the threshold for favorable sequences at an objective value above 0.9510 = 0.59,
equivalent to requiring roughly 95% occupancy on all the terms of Eq. (9). For the case where we started with
the H-RAS-SOS1 single-state designed model, 75% of the trajectories passed this threshold yielding
approximately 1400 unique sequences. Notably, none of the H-RAS sequences optimized by single-state design
to bind only SOS1 (H-RAS*,SOS1) (Fig. 3 and Table S1) overlapped any of the fuzzy-logic designed sequences.
Further, theobjective function calculated for the single-state designedH-RASwas0.35,well below theacceptance
threshold of 0.59, indicating that this design is suboptimal with respect to the set of constraints encoded inEq. (9).
Even though the resulting sequence space is large, on a position-by-position basis, the designedH-RASproteins
converge on amino acid identities that are physicochemically similar to the natural H-RAS (Fig. 4). Further, in
several trajectories, produced from simulations that started with H-RAS designed solely to bind SOS1 and
optimized using Eq. (9), the natural H-RAS sequence was retrieved as is and was ranked in the top 15% of all
designed sequences. Although the natural H-RAS sequence is ranked high, there are 108 unique sequences in
the set that converge to similar but not identical sequences (Fig. 4) and are predicted to have superior objective
function values [Eq. (9)] compared to the natural H-RAS. Inaccuracies in the energy function and in the
optimization objective function could account for this result, and otherH-RASproperties thatwerenot encodedby
Eq. (9) might be compromised by these nonnatural sequences; alternatively, these solutions comprise variants
predicted to have comparable or better stability and binding properties relative to the natural H-RAS for the
chosen partners. Thus, the use of a gradual response curve [the sigmoid of Eq. (6) and Fig. 1a], rather than
all-or-none thresholds, enables ranking the optimized sequences and provides testable hypotheses for
structure–function studies.
Orthogonal-specificity design by combining positive and negative design constraints
The challenge in orthogonal-specificity design is generally defined as follows: starting from a natural
complex of known structure, design a pair of proteins that bind as tightly as the natural complex but will bind
their natural partners more weakly. Orthogonal specificity is a crucial determinant of the function of biological
systems, insulating homologous signaling and metabolic pathways from one another, and has received
several treatments from computational protein design [31,32,58,60,67].
To test the new design strategy in this context, we analyze two complexes from the bacterial E colicin
endonuclease-immunity family, endonuclease-immunity 2 (E2,Im2) and endonuclease-immunity 9 (E9,Im9) [69].
4132 ‘Fuzzy’-logic designThe two pairs share the same overall folds, binding mode, and an identical set of residues at the core of the
binding site (the interaction hotspot). There are, however, significant differences in the identities of interface
residues outside the core. Additionally, one of the interfacial loops on the immunity protein differs in
conformation, resulting in a 5.6° reorientation of the partners in one complex relative to the other [70]. The net
effect of these molecular differences is that both cognate pairs are highly specific and bind with femtomolar
dissociation constants, while the noncognate pairs interact with 6–7 orders of magnitude lower affinities [71,72].(a) (b)
(c) (d)
(e) (f)
Fig. 4. Fuzzy-logic design converges on amino acids with physicochemical properties that resemble those of the natural
H-RAS. Sequence logos [68] of the natural, positive-only, and fuzzy-logic designed sequences of two structures with distinct
conformations:H-RASSOS1 andH-RASRal-GDS.All designablepositionsexhibit two features: (i) a different sequence is compatible
with eachstructure after positivedesignand (ii) the sequencesof the twoconvergeafter thedesign to identities physicochemically
similar to those observed in the natural sequence.
4133‘Fuzzy’-logic designThis colicin family has been subjected previously to a specialized heuristic for specificity design producing
designed partners that bound one another 2–3 orders of magnitude more tightly than their interactions with the
noncognate natural partners and with 2–4 orders of magnitude lower affinity than observed for natural colicin
pairs [56,58].
Here, we show that subjecting the E9-Im9 naturally occurring high-affinity complex to the orthogonal-specificity
design objective function defined below reproduces the required energy and structure characteristics seen in
natural high-specificity pairs and in more specialized computational specificity-design heuristics:
O ¼ B E9; Im9ð Þ∧S E9ð Þ∧S Im9ð Þ∧ IB E9; Im9ð Þ∧ IB E9; Im9ð Þ ð10Þ
where B and S are the binding and stability fractional occupancies determined from Eq. (6), E9 and Im9 are the
natural sequences, and E9* and Im9* are the designed sequences. The first three terms in Eq. (10) ensure that the
designed complex affinity and the designed monomer stabilities are maintained close to their levels in the natural
complex, while the last two terms disfavor cross-binding of each of the designed partners to its original naturalFig. 3. Single-state design versus fuzzy-logic design of the multispecific hub protein H-RAS. This view focuses on H-RAS
switch I loop. The two H-RAS complexes presented here, H-RASSOS1 (a–e) and H-RASRAS-GAP (b–f), have different backbone
conformations. Upper panel: structures of the native complexes of H-RASSOS1 (violet) and SOS1 (orange) complex (a) and
H-RASRAS-GAP (violet) and RAS-GAP (cyan) complex (b), where I380, L359, and I36 form favorable van derWaals contacts and
K398 and D33 form a salt bridge. Middle panel: single-state design of H-RASSOS1*,SOS1 complex, where D38S and I36S are
introduced to form a hydrogen bond (c), and the designed sequence of H-RASSOS1* threaded on H-RASRAS-GAP backbone,
where I36Spackingwith I380andL359 is compromised (d). Bottompanel: fuzzy-logic designofH-RAS in complexwithSOS1 (e)
and with RAS-GAP (f). Position 36 was restored to Ile, which is the natural identity, while position 38 was designed to Glu, which
forms a newelectrostatic interactionwith K398 inH-RASRAS-GAP*,RAS-GAPstructure (f), resulting in a sequence that is similar to
the wild type.
4134 ‘Fuzzy’-logic designpartner. Thus, Eq. (10) demonstrates the flexibility and expressiveness of the fuzzy-logic framework, which can be
readily extended to situations where some target states are disfavored.
The colicin pairs 2 and 9 present a unique case, where molecular structures for two cognate pairs [70,73]
and one of the noncognate pairs (E9, Im2) [74] are available. These structures allow us to estimate the
computed energies that are required for establishing high-affinity cognate binding and medium-affinity
noncognate binding in our simulations. The two cognate pairs (E2,Im2 and E9,Im9) have calculated binding
affinities below −32 R.e.u., whereas the noncognate pair (E9,Im2) has calculated binding affinity of −
27 R.e.u. We therefore set the offset value for noncognate binding [o in Eq. (6)] to −27 R.e.u., meaning that(a) Knobs-into-holes:
(b) Polarity switch:the fractional occupancy value [Eq. (6)] for a
designed noncognate pair with computed binding
energy as the natural noncognate E9,Im2 pair would
be one-half (all other parameters are provided in
Supplemental Experimental Procedures).
Starting from the molecular structure of the E9-Im9
complex [73], we select nine positions at the binding
surfaces of the immunity and endonuclease pair that
were experimentally shown to contribute to specificity
[four on the immunity (Thr27, Leu33, Val34, Thr38) and
five on the endonuclease (Ser77, Ser78, Tyr83, Lys97,
Val98)] [71]. These positions are subjected to stochas-
tic sequence optimization using the objective function
defined in Eq. (10). Unlike the specialized schemes
used previously [58], we employ the same simulated
annealing Monte Carlo sampling method used above
for the calculation of multispecificity. The difference
between the H-RAS multispecificity implementation
above and colicin orthogonal-specificity design here isFig. 5. Two designed specificity switches in the colicin
endonuclease-immunitypairE9-Im9. Interactionswithbinding
energy greater than or equal to −27 R.e.u. are noncognate
(seeResults), while interactions with binding energy less than
or equal to −33 are expected to be as favorable as the natural
pairs. Im9 andE9 are shown in green and deep-teal cartoons,
respectively. The mutated residues in the design pair are
shown in violet. (a) A design pair in which specificity is
encoded by knobs-into-holes features. In the natural pair
(upper left panel), L33 and V34 of Im9 pack against S78 and
V98 of E9, respectively. In the design pair (lower right panel),
L33V mutation introduces a smaller side chain, and the
complementary S78L mutation maintains packing density as
in the natural pair. Similarly, V34F introduces a large
side-chain in the designed Im9* while V98G removes a
side-chain. In the designed noncognate pair E9,Im9*, V34F
forms a steric overlap with E9's V98, thus destabilizing the
bound state. Similarly, in the designed noncognate pair E9*,
Im9mutationS78L forms a steric overlapwith Im9's L33. (b) A
design pair, in which specificity is encoded through a switch in
polarity features. The natural interaction is mainly based on
hydrophobic packing. In the designed pair (bottom right), K33
forms hydrogen bonds with D83 and N78, as well as a salt
bridge with D83. In the designed noncognate pairs, the
hydrogen bonds are not formed and polar residues pack
against hydrophobic ones leading to electrostatic frustration
similar to the observation in the natural noncognate pair [74].
Also, there are steric overlaps in the designed noncognate
pairs that further destabilize the bound state. In E9*, Im9's
(bottom left) D83 and N78 pack against the hydrophobic L33.
A steric overlap is formedbetweenL33andN78. In the design
noncognate pair E9,Im9*, K33 packs against S78 and Y83,
resulting in steric overlap.
4135‘Fuzzy’-logic designrestricted solely to the objective function [Eqs. (9) and (10), respectively].
As in the design of multispecificity mentioned above, orthogonal-specificity design does not converge on
a single solution, but rather it produces hundreds of sequences that meet the threshold values for individual
partner stabilities, high cognate binding affinity, and low affinities toward the respective natural (noncognate)
partners (Fig. 5). In fact, for the top designs, the resulting energy gap between the designed cognate and
designed noncognate pairs (N10 R.e.u.; Fig. 5) is calculated to be larger than that computed for the natural
pairs. The molecular details of the designed complexes reproduce the hallmarks of high-affinity and
high-specificity complexes, as seen in natural colicin complexes [74], including intricate van der Waals
packing and hydrogen-bonding networks in the designed cognate complexes (E9*,Im9*). Conversely, the
modeled noncognate complexes (E9*,Im9 and E9,Im9*) exhibit electrostatic and steric frustration (Fig. 5).
Even though we use only a single design heuristic and objective function, different trajectories result in quite
different solutions to encoding specificity; these include, in the two cases highlighted in Fig. 5, one that employs
knobs-into-holes to introduce steric overlaps in noncognate pairs and another that uses electrostatic frustration to
achieve the same goal. Fuzzy-logic design can therefore define several physicochemically distinct ways of
achieving the samedesired function.Wenote, however, that, in the natural colicin family, specificity is also encoded
by backbone conformation changes andperturbations to the rigid-body orientations [74] and that recapitulating
natural sequences in this family likely requires modeling these degrees of freedom. The objective function
defined in Eq. (10) can indeed be used to guide an optimization algorithm that samples sequence, as well
as backbone and rigid-body conformations (Lapidoth et al., unpublished results) [56,75].Discussion
The evolution of a biological macromolecule is
subject to selection pressures that bear on its physical
properties, such as stability, binding affinity, specificity,
and activity. We presented a framework for encoding
eachphysical constraint based on the equilibrium-ther-
modynamics concept of fractional occupancy of the
target state within an ensemble of states. In the
example of H-RAS, multispecificity design specified a
large number of physical properties, overall encoding
10 different constraints relating to both stability and
binding affinity. These 10 constraints were combined
using Boolean operators to recapitulate sequences
and conformations observed in nature, including the
natural H-RAS sequence. By changing the objective
function only and without changing the underlying
optimization algorithm, we can alsomodel competition
with alternative states, as seen in specificity-switch
modeling. The result is a general language for
encoding different physical traits, including ones
that exhibit tradeoffs with one another, as logical
expressions that can be translated into a numerical
objective function for optimization. In reality, the
tradeoffs between different physical properties
extend beyond purely thermodynamics properties
and also involve kinetics [15,76] and, specifically,
association and dissociation rate constants. Where
structural data are available on kinetic intermedi-
ates and parameters, kinetic constraints could also
be modeled using the same framework, as could
other important properties such as selectivity. We
expect the fuzzy-logic design scheme to work well in
cases where large structural differences between
the alternative states exist and where the desired
energy gaps between target and off-target states
are large, as in the case studies selected here.Encoding fine discrimination between structurally
similar states or small energy gaps may require
refined energy functions.
Not all properties of biological systems are
explained within the context of optimality and
adaptation [77]; however, the physical constraints
shaping biomolecules and biomolecular structures
are largely known. The computational framework
suggested here can be useful for a quantitative
analysis of these constraints and for the design of
novel biomolecules with desired functions. The
design of novel or rewired signaling and metabolic
networks [78], for instance, inevitably invokes
complex tradeoffs between different molecules
and their properties, and these can also be encoded
within the framework presented here. Recent
advances in the application of deep sequencing to
libraries of natural protein variants [79,80] and of in
vitro mutational repertoires selected for complex
combinations of physical features, including stabil-
ity, binding, and specificity profiles [34,36,81–83]
are generating datasets comprising thousands of
mutants that relate sequence changes to function at
unprecedented resolution and coverage [84]. The
fuzzy-logic design framework described here can be
used to test hypotheses relating sequence, struc-
ture, and energetics to function, as well as in turn to
fitness. Interpreting these empirical data through
fuzzy-logic design may ultimately lead to a better
understanding and ability to manipulate the multiple
physical properties and tradeoffs that shape the
evolution of biomolecular functions. More broadly,
tradeoffs in biology extend beyond the molecular
level to the evolution of organism phenotypes [85];
the use of sigmoid functions to represent the levels
at which individual traits reach sufficiency and fuzzy
logic to integrate these into optimization objective
4136 ‘Fuzzy’-logic designfunctions that resemble natural language could thus
be generalized beyond the molecular level explored
here.Experimental Procedures
Sequence optimization
For both multispecificity and orthogonal-specificity
design, we start from wild-type complexes of solved
molecular structure, relaxed using procedures de-
scribed in Supplemental Experimental Procedures,
and compute the binding and stability energies of each
component in the natural system. For each design
objective, the o and s parameters of the fractional
occupancy equation [Eq. (6)] are computed to reflect
the desired energies of each modeled state (see
Results and Supplemental Experimental Procedures).
Each design task is assigned a different objective
function [e.g., Eqs. (9) and (10)] to reflect its unique
biomolecular constraints. We then select a set of
interface residues for stochastic sequence optimiza-
tion. At each step of the optimization trajectory, a single
position is chosen at random out of the set of positions
allowed to optimize (including on both sides of the
interface in the case of orthogonal-specificity design),
and a substitution to a randomly chosen identity is
introduced in all modeled protein states (i.e., unbound
for stability calculations and bound to each of the
partners in the case of binding calculations); each state
is then subjected to the same energy-relaxation
protocol, including combinatorial side-chain packing
and side-chain and rigid-body minimization. All ener-
gies are computed with the Rosetta all-atom energy
function, which is dominated by contributions from van
der Waals packing, hydrogen bonding, and solvation
[86]. A new state is accepted subject to the Metropolis
criterion and the mutation and selection process is
repeated. Additional implementation details are pro-
vided in Supplemental Experimental Procedures,
including complete RosettaScripts [87] and execution
instructions for each design task.
Binding and stability calculations
Binding energies are computed as the difference
in system energy between the bound repacked model
and the repacked monomers when taken apart from
one another and are substituted for x in Eq. (6) to
produce the bound fractional occupancy [B in
Eqs. (7)–(10)]. Monomer stability is the system energy
of the monomer in its bound conformation but
dissociated from the ligand, and it is likewise substitut-
ed for x in Eq. (6) to produce the folded fractional
occupancy [S in Eqs. (7)–(10)]. For example,
B(H-RASpartner*,partner) of Eq. (9) is the fractional
occupancy as a function of the binding energy ofthe H-RAS mutant for its partner and S(H-RASpartner*)
is the fractional occupancy as a function of the stability
of the H-RASmutant monomeric form modeled on the
backbone observed in the partner-bound molecular
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